Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descartes-08 for Patients With Systemic Lupus Erythematosus

NCT06038474 is registered in ClinicalTrials.gov with Cartesian Therapeutics as lead sponsor.

NCT NCT06038474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06038474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descartes-08 for Patients With Systemic Lupus Erythematosus
Lead sponsor
Cartesian Therapeutics
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 12, 2024
Completion date
December 1, 2027
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus (sle)